Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,377.60
(
-1.44%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
106.55
(
2.27%
)
Bitcoin
80,416.46
(
-0.79%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 24
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: DewDiligence post# 129438

Wednesday, 10/26/2011 3:18:47 PM

Wednesday, October 26, 2011 3:18:47 PM

Post# of 257566
Dew, even if the trial was not powered to determine superiority over copaxone, if BG-12 would have "beat copaxone with ease", then it would have been statistically superior. It obviously was not as it was not included in the PR. Too me, this means they are equivalent in my book
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today